A Multicentre, Randomised, Double Blind Placebo Controlled Trial Evaluating Atorvastatin in Factorial With Omega-3 Fatty Acids Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
A Multicentre, Randomised, Double Blind Placebo Controlled Trial Evaluating Atorvastatin in Factorial With Omega-3 Fatty Acids Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
The AFORRD trial is asking three important questions:
What proportion of people with Type 2 Diabetes are likely to be treated satisfactorily with a fixed dose of a statin that lowers blood cholesterol levels to help reduce the risk of heart disease? To what extent do omega-3 fatty acids lower blood triglyceride levels when given with or without a statin? Are there simple techniques that can help people to take their tablets on a regular basis?
Inclusion Criteria:
Exclusion Criteria:
Dronfield, Sheffield, England S18 1RU, United Kingdom
Surrey, England CR7 7JN, United Kingdom
Thorneton-Clevely, Lancashire FY5 3LF, United Kingdom
Bucks, HP22 5LB, United Kingdom
Cornwall, TR18 2RE, United Kingdom
County Antrim, Northern Ireland, BT41 3AE, United Kingdom
East Sussex, TN40 3RJ, United Kingdom